Ignite Creation Date:
2024-05-06 @ 3:55 PM
Last Modification Date:
2024-10-26 @ 1:59 PM
Study NCT ID:
NCT04804514
Status:
COMPLETED
Last Update Posted:
2023-11-01
First Post:
2021-03-09
Brief Title:
Evaluation of the Safety and Tolerability of KH001 in Dentin Hypersensitivity Patients
Sponsor:
HysensBio Co Ltd
Organization:
HysensBio Co Ltd
Study Overview
Official Title:
Phase 12a Study of KH001 in Dentin Hypersensitivity Patients
Status:
COMPLETED
Status Verified Date:
2023-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a phase 12a study in dentin hypersensitivity patients to assess the safety tolerability efficacy and pharmacokinetics of single and multiple doses of KH001
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None